You are here:   Home > Announcement Details
Register   |  Login

Allows pharmacists to administer HPV Vaccine and other vaccines to children

Location: HI
Title: Allows pharmacists to administer HPV Vaccine and other vaccines to children
Identifier: HB 676/SB 514
Stance: OPPOSE
Action Required: None at this time
Status: Enacted, Effective 7/3/2017, Act 068


UPDATE: SB 514 was signed by the governor and went into effect on 7/3/2017.  

UPDATE: 7/5/2017 - SB 514 is still pending the governor's signature.  This bill will become effective on approval. HB 676 died because the companion was passed. 

UPDATE: 5/5/2017 - SB 514 was sent to the governor on 5/4/2017.

UPDATE: SB 514 is in the final stages of approval after it was passed by a conference committee on 4/27/2017 and final readings in the house and senate on 5/3/2017.  The amended bill passed by the committee does not address parental consent. - conference committee report

UPDATE: 3/29/2017 - SB 514 passed by the CPC on 3/28/2017.

UPDATE: 3/27/2017 - SB 514 is scheduled to be heard by CPC on 3/28/2017 2:00 PM in House conference room 329.

UPDATE : 3/19/2017 - SB 514 passed the House Committee on HLT on 3/16/2017.

UPDATE: 3/13/2017 - SB 514 scheduled to be heard by HLT on Tuesday, 3/14/17 at 8:30AM in House conference room 329.

UPDATE: 3/10/2017 - SB 514, the companion bill for HB 676 passed the full senate after being amended to include - 

     (1)  Clarifying that pharmacists are authorized to administer the Tdap (tetanus, diphtheria, pertussis), meningococcal, and influenza vaccines, in addition to the human papillomavirus vaccine, to persons between eleven and seventeen years of age; See the committee report - 

The bill has been referred to the House HLT and CPC Committees. 

UPDATE: 3/9/2017 - HB 676 is currently deferred by the CPC Committee. 

UPDATE 2/24/2017: HB 676 is scheduled for decision making on Wednesday, 3/1/17 1:55 PM in conference room 329.

UPDATE 2/22/2017: HB 676 is scheduled for a hearing in House Committee on Consumer Protection & Commerce on 2/23/2017 at 2:00 PM in the House conference room 329.

UPDATE 2/8/2017: HB 676 passed the House Committee on Health on 2/7/2017.  Committee report - 

UPDATE 2/4/2017:  HB 676 was scheduled for a hearing 2/7/2017 at 9:30AM in House conference room 329.

UPDATE 1/31/2017: HB 676 was referred to the House Committee on Health on 1/25/2017.

HB 676 was introduced and had first reading on 1/23/2017.  This bill is sponsored by Representatives Belatti, Ichiyama, Lopresti, Mizuno and Morikawa.  

This bill would expand current law that allows pharmacists to administer vaccines to children 14 to 17 to include HPV (Human papillomavirus) Vaccines to children 11 to 17 according to current section 461-11.4.

Current law does not specifically require parental consent:

Hawaii Revised Statutes Division 2. Business § 461-11.4

(a) A pharmacist may administer a vaccine to persons between fourteen and seventeen years of age pursuant to a valid prescription.  The pharmacist shall verify that the prescriber or the prescriber's authorized agent is the patient's medical home.

(b) After the vaccination is administered, the pharmacist shall immediately provide to the patient a vaccination record including the following information:

1) The patient's name and date of birth;

(2) The type of vaccine administered;  and

(3) The date and location that the vaccine was administered.

(c) The pharmacist shall provide within seventy-two hours to the medical home and within five business days to the department of health immunization registry the same information provided to the patient pursuant to subsection (b) as well as the following:

(1) The name of the vaccine product that was administered, including the manufacturer, lot number, and expiration date;

(2) The method of administration;  and

(3) The anatomical site of administration.

(d) All pharmacists who administer vaccines to persons between the ages of fourteen and seventeen years shall complete a training program approved by the Accreditation Council of Pharmacy Education for which a certificate of completion is issued.  The pharmacist shall complete the training program and submit the completion certificate for the training program to the board prior to administering any vaccine to persons between the ages of fourteen and seventeen years.

(e) For the purposes of this section, “medical home” means the primary care physician who, working in collaboration with the family, oversees the acute, chronic, and preventive health needs of the patient in a comprehensive, coordinated, and continuous fashion.

- See more at: